First Patients Treated Using the LV Y-90 Disc and iWand A!
First patients are treated using the LV Y-90 Disc and iWand A.
News
Northwell Depth-Dose Study to be presented at AAPM!
Northwell depth-dose study to be presented at the AAPM annual meeting.
Pilot Production Begins
Pilot production begins at Liberty Vision.
Liberty Vision CEO Contributes to New Book
Liberty Vision CEO Dr. Paul T. Finger contributes to a new book on surgical ophthalmic oncology.
Liberty Vision Secures Larger Facilities
Liberty Vision secures larger facilities to support growing operations.
Testing and Qualification of Device Production and Processes Underway
Testing and qualification of device production and processes is underway.
Key US Patents Granted for the iWand® Device, its Key Technologies and Variants
Several key US patents granted for the iWand® device, its key technologies, and variants.
Patents Granted for the iWand® Source in US and Europe
Patents granted for the Liberty Vision iWand® source in the US and Europe.
Manufacturing Start-up Begins
Liberty Vision manufacturing start-up begins.
IP Refinement Completed & Multiple Additional Patent Applications Submitted
IP refinement completed and multiple additional patent applications submitted.